Suppressing key enzymes could improve lung cancer treatment outcomes

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer, according to a new Yale study.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup